Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CCEL vs KOOL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CCEL Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 7–1 Matrix Metrics)

CCEL Overall Winner 6-Pillar Tally: CCEL 5 – 0 KOOL (1 Tie) Matrix Metrics: CCEL 7 – 1 KOOL

As of Nov 20, 2026, Cryo-Cell International Inc. (CCEL) is the stronger overall head-to-head candidate over North Shore Equity Rotation ETF (KOOL) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CCEL carries a Unified Composite Score of 50.8/100 (HOLD) at $4.15 (N/M Forward P/E, 0.6% operating margin), whereas KOOL carries 43.6/100 (HOLD) at $12.80 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: CCEL trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 39.6); meanwhile KOOL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 22.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CCEL vs KOOL
CCEL NYSE American Head-to-Head Winner
Cryo-Cell International Inc.
Services-Misc Health & Allied Services, Nec
$4.15
+0.0% 1D
Market Cap $33.5M
TTM Revenue $31M
Forward P/E N/M
Beta / 30D Vol 0.44β · 79% Vol
Unified Composite Score
50.8 / 100 HOLD
Tech 22.0 Fund 44.0 Flow 50.0 Mom 56.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 40
RSI-14: 39.6 · SMA20: $4.88 · SMA50: $4.48
KOOL NYSE Arca
North Shore Equity Rotation ETF
Institutional Equity
$12.80
-4.0% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.04β · 24% Vol
Unified Composite Score
43.6 / 100 HOLD
Tech 29.0 Fund 44.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.0%), weak momentum, RSI 22
RSI-14: 22.0 · SMA20: $13.98 · SMA50: $14.40

6-Pillar Scorecard Institutional Category Breakdown (CCEL 5 – 0 KOOL)

Columns: Metric · CCEL · KOOL
1. Valuation Multiples CCEL
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio 1.34x N/M
EV / Revenue 1.1x N/M
2. Growth & Scale CCEL
Revenue Growth (YoY) +0.0% N/A
Earnings Growth (YoY) +75.1% N/A
TTM Revenue (USD) $31M N/A
Market Cap $33.5M N/A
3. Profitability & Quality CCEL
Gross Margin 64.5% N/A
Operating Margin 0.6% N/A
Net Profit Margin -6.2% N/A
Return on Equity (ROE) 129.2% N/A
4. Balance Sheet & Cash Flow CCEL
Cash Generation (TTM) $1.2M EBITDA N/A
Cash Flow Margin 3.7% EBITDA Mgn N/A
Net Cash / Leverage 129.2% ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat CCEL
OpEx & R&D Intensity 63.9% of Rev ($20M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Care Facilities Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CCEL (7) vs KOOL (1)
Institutional Metric CCEL KOOL Criterion Row Edge
Market Capitalization
Scale
$33.5M N/A Larger Scale CCEL
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% N/A Higher Growth CCEL
Operating Margin (TTM)
Profitability
0.6% N/A Higher Margin CCEL
Net Profit Margin
Profitability
-6.2% N/A Higher Margin CCEL
Return on Equity (ROE)
Capital Efficiency
129.2% N/A Higher ROE CCEL
52-Week Range Position
Momentum
52% ($3–$5) 19% ($12–$15) Stronger Trend CCEL
Beta / 30D Volatility
Risk Regime
0.44β · 79% Vol 1.04β · 24% Vol Lower Realized Risk KOOL
Unified Institutional Score
Composite Signal
50.8 / 100 (HOLD) 43.6 / 100 (HOLD) Higher Composite CCEL
Trailing 12M Revenue (USD)
Operating Scale
$31M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
64.5% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.34x PEG · 1.1x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.2M EBITDA (129.2% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CCEL +3.34 pp
CCEL: -7.57% · KOOL: -10.91%
3M Horizon CCEL +6.82 pp
CCEL: -5.47% · KOOL: -12.29%
6M Horizon CCEL +32.31 pp
CCEL: +20.64% · KOOL: -11.67%
1Y Horizon KOOL +0.46 pp
CCEL: +2.22% · KOOL: +2.68%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CCEL vs KOOL. Trailing 12-month operating profitability (CCEL 0.6% vs KOOL N/A) and valuation multiples (CCEL N/M vs KOOL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CCEL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$31M
Gross Margin64.5%
Op. Margin0.6%
ROE / Fwd P/E129.2% · N/M
KOOL ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CCEL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CCEL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
KOOL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KOOL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CCEL Moat Profile High-Margin Pricing Power Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $33.5M market capitalization and 0.6% operating margin.
OpEx & R&D Reinvestment 63.9% of Rev ($20M)
90D Engineering Disclosures 0 Published
KOOL Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CCEL vs KOOL Key Questions & Quantitative Answers

As of Nov 20, 2026, Cryo-Cell International Inc. (CCEL) is the stronger overall head-to-head candidate over North Shore Equity Rotation ETF (KOOL) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CCEL carries a Unified Composite Score of 50.8/100 (HOLD) at $4.15 (N/M Forward P/E, 0.6% operating margin), whereas KOOL carries 43.6/100 (HOLD) at $12.80 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: CCEL trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 39.6); meanwhile KOOL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 22.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CCEL leads the Growth & Scale pillar: CCEL posts +0.0% YoY revenue growth and +75.1% YoY earnings growth on $31M TTM revenue (64.5% gross margin, 0.6% operating margin), compared with KOOL at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, CCEL generates $31M in USD-normalized revenue versus N/A for KOOL. In operating R&D and SG&A reinvestment, CCEL deploys 63.9% of Rev ($20M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for KOOL.

CCEL screens cheaper on headline valuation multiples. CCEL trades at N/M Forward P/E, N/M Trailing P/E, 1.34x PEG, and 1.1x EV/Revenue (3.7% EBITDA margin), whereas KOOL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CCEL (129.2% ROE) versus KOOL (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, CCEL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 79% Vol realized risk). By comparison, KOOL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.04β · 24% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.